Bio-Techne Expands AI-Engineered Designer Protein Portfolio for Cell Therapy Workflows

Advancing Scalable Reproducible Cell Therapy and Advanced Cell Culture Workflows New heat-stable and hyperactive proteins across the fibroblast growth...

July 10, 2026 | Friday | News
Keenova Reports Positive Phase 3 Results for XIAFLEX in Plantar Fibromatosis

Keenova Therapeutics plc announced  positive results from its Phase 3 clinical trial of XIAFLEX® (collagenase clostridium histolyticum) for the ...

July 10, 2026 | Friday | News
Applied StemCell and RoosterBio Partner to Advance Scalable iPSC Manufacturing

Partnership pairs Applied StemCell's induced pluripotent stem cell technology with RoosterBio's engineered media, reagents, and scalable bioprocess syste...

July 10, 2026 | Friday | News
Evogene and Tel Aviv University Launch AI-Driven Small Molecule Drug Discovery Initiative

Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational chemistry company focused on the generative design of small molecules for the pharmaceuti...

July 10, 2026 | Friday | News
Wave Life Sciences Gains Shareholder Approval for Proposed US Redomiciliation

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform huma...

July 09, 2026 | Thursday | News
Danaher’s Abcam Partners with EpiCypher to Advance Epigenomics Research

Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, and EpiCypher®, the leading provider of ChIC/CU...

July 09, 2026 | Thursday | News
Thermo Fisher’s Applied Biosystems RapidINTEL Plus Cartridge Receives FBI Approval for CODIS-Eligible Rapid DNA Crime Scene Profiles

Product: Applied Biosystems™ RapidINTEL™ Plus Cartridge used with the Applied Biosystems™ RapidHIT ID™ System Category: Rapid ...

July 09, 2026 | Thursday | News
Vaxart Reports Positive Phase 2b Safety Data for Oral Pill COVID-19 Vaccine Candidate

Vaxart, Inc. announced topline data from the approximately 400-participant sentinel safety cohort of its Phase 2b clinical trial evaluating the Company&r...

July 08, 2026 | Wednesday | News
Alberta Cancer Foundation Commits $35 Million to Expand Cancer Clinical Trials Across Alberta

The Alberta Cancer Foundation is investing $35-million to advance cancer clinical trials in Alberta. The amount represents one of the largest investment...

July 08, 2026 | Wednesday | News
Vertex to Acquire Crinetics in a $10 Billion Deal to Expand Rare Endocrine Disease Portfolio

Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex’s portfo...

July 08, 2026 | Wednesday | News
Ribo and Madrigal Reach First siRNA Candidate Milestone in MASH Drug Development Partnership

Suzhou Ribo Life Science Co., Ltd. (06938.HK), and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as "Ribo"), in collaboration with...

July 07, 2026 | Tuesday | News
Insilico Medicine and Takeda Forge Up to $600 Million AI Drug Discovery Collaboratio

Partnership to leverage Pharma.AI platform for novel drug candidates across Takeda's therapeutic areas Insilico Medicine ("Insilico" HKEX:3696), a ...

July 07, 2026 | Tuesday | News
ProBio Supports Advancement of UC Irvine and GlyTR's Next-Generation AAV CAR-T Platform Toward Clinical Development

The University of California, Irvine (UC Irvine) School of Medicine and GlyTR Therapeutics have developed a next‑generation AAV‑mediated CAR T‑cell...

July 06, 2026 | Monday | News
Nona Biosciences and Lonza Partner to Advance Next-Generation BBB-Crossing Technology for CNS Therapies

Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, announce...

July 06, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close